Desk›Information Technology› Zensar Technologies Ltd
Zensar Technologies Ltd
BSE 504067 · NSE ZENSARTECH · ISIN INE520A01027 · Group A · Active
Information Technology › Information Technology › IT - Software › Computers - Software & Consulting
₹464.35
-1.57%
BSE close, 28 August 2026
₹10,566.52 cr
22.8 cr shares · Small cap
₹5,273.82 cr
as published
15.2× · 3.81×
EPS ₹30.66 · BV ₹121.88
2,738.80 / 686.00
₹ cr, as filed
25
6 selected · 24%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -46.5% |
|---|---|
| Against 52-week low | +9.7% |
| Day change | -1.57% |
| Size band | Small cap |
| Index membership | NIFTY 500 |
Valuation as published by BSE
| Earnings per share | ₹30.66 |
|---|---|
| Price / earnings | 15.15× |
| Price / book | 3.81× |
| Book value — derived, price ÷ P/B | ₹121.88 |
| Return on equity | 25.14% |
| Operating margin | 32.82% |
| Net margin | 24.04% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 25.15%
- ROE as published
- 25.14%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 763.20 | 183.50 | 8.09 | 32.82% | 24.04% |
| Mar-26 · Q | 741.80 | 199.20 | 8.79 | 34.50% | 26.85% |
| FY25-26 | 2,738.80 | 686.00 | 30.22 | 33.10% | 25.05% |
Quarter on quarter
- Revenue, quarter on quarter
- +2.9%
- Net profit, quarter on quarter
- -7.9%
- Operating margin, quarter on quarter
- -168 bps
Disclosure profile 25 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Board Outcome | 1 |
| Concall Transcript | 1 |
| Credit Rating | 1 |
| Investor Presentation | 1 |
| Press Release | 1 |
| Results | 1 |
| Selected sub-total | 6 |
| Procedural | |
| Analyst / Investor Meet | 4 |
| General | 4 |
| ESOP Allotment | 3 |
| AGM / EGM | 2 |
| Board Meeting | 2 |
| Annual Report | 1 |
| Compliance Certificate | 1 |
| Newspaper Publication | 1 |
| Trading Window | 1 |
| Procedural sub-total | 19 |
| Total | 25 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group A, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
25 filings · 6 selected · busiest 2026-07-29
Filing rhythm · the twelve most recent
2026-07-312026-10-08
SelectedProcedural
Filings
25 in the window · 13 earlier on record
-
8 October 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate Under Reg. 74(5) of SEBI (DP) Regulations 2018 for quarter ended September 30, 2026.
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
7 October 2026 ·
Allotment of ESOP / ESPS
Intimation about allotment of Equity shares by Nomination and Remuneration Committee
Company Update / Allotment of ESOP / ESPS View filing →
-
7 October 2026 ·
Board Meeting Intimation for Considering And Approving The Un-Audited Financial Results For The Quarter Ended September 30, 2026 And To Consider Any Other Matter(S), If Any
Zensar Technologies Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2026 ,inter alia, to consider and approve the Un-audited Financial ....
Board Meeting / Board Meeting View filing →
-
30 September 2026 ·
Closure of Trading Window
Intimation for Trading Window Closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Insider Trading / SAST / Closure of Trading Window View filing →
-
31 August 2026 ·
Credit Rating
Intimation under Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015- Credit Rating
Company Update / Credit Rating View filing →
-
24 August 2026 ·
Allotment of ESOP / ESPS
Intimation about allotment of Equity Shares by the Nomination and Remuneration Committee
Company Update / Allotment of ESOP / ESPS View filing →
-
14 August 2026 ·
Update On Merge Of US Subsidiary
In continuation to our letter dated July 29, 2026, this is an update on merger of M3BI LLC with Zensar Technologies Inc.
Company Update / General View filing →
-
10 August 2026 ·
Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst/Institutional Investor meeting
Company Update / Analyst / Investor Meet View filing →
-
10 August 2026 ·
Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst/Institutional Investor meeting
Company Update / Analyst / Investor Meet View filing →
-
5 August 2026 ·
Earnings Call Transcript
Earning Call Transcript Q1 FY27
Company Update / Earnings Call Transcript View filing →
-
31 July 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Voting Results and Scrutinizer's Report for the 63rd Annual General Meeting of the Company
AGM/EGM / AGM View filing →
-
31 July 2026 ·
Newspaper Publication
Copies of newspaper advertisement of the unaudited Financial Results published in Financial Express (all India edition) and Loksatta (Pune edition) on July 31, 2026 which were approved ....
Company Update / Newspaper Publication View filing →
-
31 July 2026 ·
Update On Merge Of US Subsidiary
This in continuation of our letter dated July 29, 2026, this is an update on the merger of Bridgeview Life Sciences LLC with Zensar Technologies Inc.
Company Update / General View filing →
-
30 July 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of 63rd Annual General Meeting of the Company held on July 30, 2026
AGM/EGM / AGM View filing →
-
30 July 2026 ·
Analyst / Investor Meet - Outcome
Audio Recording of Q1FY27 Results Earnings Call held on July 30, 2026
Company Update / Analyst / Investor Meet View filing →
-
29 July 2026 ·
In-Principle Approval For Merger Of The US-Based Step-Down Subsidiary(Ies) Of The Company
In-principle approval for Merger of the US-based step-down subsidiary(ies) of the Company
Company Update / General View filing →
-
29 July 2026 ·
-
29 July 2026 ·
Press Release / Media Release
Press Release and Investor Presentation
Company Update / Press Release / Media Release View filing →
-
29 July 2026 ·
-
29 July 2026 ·
Board Meeting Outcome for Financial Results For Quarter Ended June 30, 2026
Financial Results for Quarter ended June 30, 2026
Board Meeting / Outcome of Board Meeting View filing →
-
27 July 2026 ·
Analyst / Investor Meet - Intimation
Q1FY27 Results Earnings Call Scheduled on July 30, 2026
Company Update / Analyst / Investor Meet View filing →
-
24 July 2026 ·
Reg. 34 (1) Annual Report.
Integrated Annual Report for FY 2025-26 - Revised
Others / Reg. 34 (1) Annual Report View filing →
-
21 July 2026 ·
Board Meeting Intimation for Considering And Approving The Un-Audited Financial Results For The Quarter Ended June 30, 2026
Zensar Technologies Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2026 ,inter alia, to consider and approve the Un-audited Financial ....
Board Meeting / Board Meeting View filing →
-
20 July 2026 ·
Allotment of ESOP / ESPS
Intimation about allotment of Equity Shares by the Nomination and Remuneration Committee
Company Update / Allotment of ESOP / ESPS View filing →
-
20 July 2026 ·
Intimation Of Grant Of Esops
Intimation about the grant of ESOPs by Nomination and Remuneration Committee
Company Update / General View filing →
RSS feed for Zensar Technologies Ltd · the 50 most recent filings